TGF-β1 mediates the radiation response of prostate cancer

被引:30
作者
Wu, Chun-Te [1 ,2 ]
Hsieh, Ching-Chuan [2 ,3 ]
Yen, Tzu-Chen [2 ,4 ,5 ]
Chen, Wen-Cheng [2 ,6 ]
Chen, Miao-Fen [2 ,6 ]
机构
[1] Chang Gung Mem Hosp, Dept Urol, Keelung, Taiwan
[2] Chang Gung Univ, Coll Med, Taoyuan, Taiwan
[3] Chang Gung Mem Hosp, Dept Gen Surg, Chiayi, Taiwan
[4] Chang Gung Mem Hosp, Dept Nucl Med, Linkou, Taiwan
[5] Chang Gung Mem Hosp, Mol Imaging Ctr, Linkou, Taiwan
[6] Chang Gung Mem Hosp, Dept Radiat Oncol, Chiayi, Taiwan
来源
JOURNAL OF MOLECULAR MEDICINE-JMM | 2015年 / 93卷 / 01期
关键词
TGF-beta; 1; Irradiation; Regulatory T cells; Prostate cancer; REGULATORY T-CELLS; GROWTH-FACTOR-BETA; EPITHELIAL-MESENCHYMAL TRANSITION; TGF-BETA; BREAST-CANCER; TUMOR MICROENVIRONMENT; HORMONE-THERAPY; PROGRESSION; RESISTANT; RADIOTHERAPY;
D O I
10.1007/s00109-014-1206-6
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Radiotherapy is the main treatment modality for prostate cancer. This study investigated the role of TGF-beta 1 in biological sequelae and tumor regrowth following irradiation, which are critical for the clinical radiation response of prostate cancer. Human and murine prostate cancer cell lines, and corresponding hormone-refractory (HR) cells, were used to examine the radiation response by clonogenic assays in vitro and tumor growth delay in vivo. Biological changes after irradiation, including cell death and tumor regrowth, were examined by experimental manipulation of TGF-beta 1 signaling. The correlations among tumor radiation responses, TGF-beta 1 levels, and regulatory T cells (Tregs) recruitment were also evaluated using animal experiments. HR prostate cancer cells appeared more radioresistant and had higher expression of TGF-beta 1 compared to hormone-sensitive (HS) cells. TGF-beta 1 expression was positively linked to irradiation and radioresistance, as demonstrated by in vitro and in vivo experiments. Inhibition of TGF-beta 1 increased tumor inhibition and DNA damage after irradiation. When mice were irradiated with a sub-lethal dose, the regrowth of irradiated tumors was significantly correlated with TGF-beta 1 levels and Tregs accumulation in vivo. Furthermore, blocking TGF-beta 1 clearly attenuated Tregs accumulation and tumor regrowth following treatment. These data demonstrate that TGF-beta 1 is important in determining the radiation response of prostate cancer, including tumor cell killing and the tumor microenvironment. Therefore, concurrent treatment with a TGF-beta 1 inhibitor is a potential therapeutic strategy for increasing the radiation response of prostate cancer, particularly for more aggressive or HR cancer cells. aEuro cent HR prostate cancer cells appeared more radioresistant and had higher expression of TGF-beta 1. aEuro cent TGF-beta 1 was positively linked to the radiation resistance of prostate cancer. aEuro cent Tumor regrowth following irradiation was significantly correlated with TGF-beta 1 and Tregs levels. aEuro cent Blocking TGF-beta 1 significantly attenuated RT-induced DNA repair and Tregs. aEuro cent TGF-beta 1 inhibitor increases the radiation response of HR cancer cells.
引用
收藏
页码:73 / 82
页数:10
相关论文
共 46 条
[1]   Salvage therapy of intraprostatic failure after radical external-beam radiotherapy for prostate cancer: A review [J].
Alongi, Filippo ;
De Bari, Berardino ;
Campostrini, Franco ;
Arcangeli, Stefano ;
Matei, Deliu Victor ;
Lopci, Egesta ;
Petralia, Giuseppe ;
Bellomi, Massimo ;
Chiti, Arturo ;
Magrini, Stefano Maria ;
Scorsetti, Marta ;
Orecchia, Roberto ;
Jereczek-Fossa, Barbara Alicja .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2013, 88 (03) :550-563
[2]   LACK OF RADIATION DOSE OR QUALITY DEPENDENCE OF EPITHELIAL-TO-MESENCHYMAL TRANSITION (EMT) MEDIATED BY TRANSFORMING GROWTH FACTOR β [J].
Andarawewa, Kumari L. ;
Costes, Sylvain V. ;
Fernandez-Garcia, Ignacio ;
Chou, William S. ;
Ravani, Shraddha A. ;
Park, Howard ;
Barcellos-Hoff, Mary Helen .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 79 (05) :1523-1529
[3]   Radiation Treatment Effects on the Proteome of the Tumour Microenvironment [J].
Atkinson, Michael J. .
RADIATION PROTEOMICS: THE EFFECTS OF IONIZING AND NON-IONIZING RADIATION ON CELLS AND TISSUES, 2013, 990 :49-60
[4]   Depletion of radio-resistant regulatory T cells enhances antitumor immunity during recovery from lymphopenia [J].
Baba, Junko ;
Watanabe, Satoshi ;
Saida, Yu ;
Tanaka, Tomohiro ;
Miyabayashi, Takao ;
Koshio, Jun ;
Ichikawa, Kosuke ;
Nozaki, Koichiro ;
Koya, Toshiyuki ;
Deguchi, Katsuya ;
Tan, Chunrui ;
Miura, Satoru ;
Tanaka, Hiroshi ;
Tanaka, Junta ;
Kagamu, Hiroshi ;
Yoshizawa, Hirohisa ;
Nakata, Ko ;
Narita, Ichiei .
BLOOD, 2012, 120 (12) :2417-2427
[5]   Advances in translational radiation oncology: From molecular signaling to cancer cure [J].
Bernier, J ;
Fuks, Z .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 58 (02) :305-306
[6]   TGFβ1 Inhibition Increases the Radiosensitivity of Breast Cancer Cells In Vitro and Promotes Tumor Control by Radiation In Vivo [J].
Bouquet, Fanny ;
Pal, Anupama ;
Pilones, Karsten A. ;
Demaria, Sandra ;
Hann, Byron ;
Akhurst, Rosemary J. ;
Babb, Jim S. ;
Lonning, Scott M. ;
DeWyngaert, J. Keith ;
Formenti, Silvia C. ;
Barcellos-Hoff, Mary Helen .
CLINICAL CANCER RESEARCH, 2011, 17 (21) :6754-6765
[7]   Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-β induction of transcription factor Foxp3 [J].
Chen, WJ ;
Jin, WW ;
Hardegen, N ;
Lei, KJ ;
Li, L ;
Marinos, N ;
McGrady, G ;
Wahl, SM .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (12) :1875-1886
[8]   Differentiation and function of Foxp3+ effector regulatory T cells [J].
Cretney, Erika ;
Kallies, Axel ;
Nutt, Stephen L. .
TRENDS IN IMMUNOLOGY, 2013, 34 (02) :74-80
[9]   TGF-β signalling and its role in cancer progression and metastasis [J].
Drabsch, Yvette ;
ten Dijke, Peter .
CANCER AND METASTASIS REVIEWS, 2012, 31 (3-4) :553-568
[10]   Tumors as Organs: Biologically Augmenting Radiation Therapy by Inhibiting Transforming Growth Factor β Activity in Carcinomas [J].
Du, Shisuo ;
Barcellos-Hoff, Mary Helen .
SEMINARS IN RADIATION ONCOLOGY, 2013, 23 (04) :242-251